- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/5386 - 1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
Patent holdings for IPC class A61K 31/5386
Total number of patents in this class: 979
10-year publication summary
|
36
|
44
|
36
|
35
|
46
|
54
|
53
|
64
|
107
|
165
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2713 |
21 |
| Bayer AG | 3381 |
17 |
| Boehringer Ingelheim International GmbH | 4649 |
15 |
| Pfizer Inc. | 3388 |
15 |
| Chugai Seiyaku Kabushiki Kaisha | 1374 |
15 |
| Merck Sharp & Dohme LLC | 3739 |
15 |
| Genentech, Inc. | 4017 |
14 |
| Vertex Pharmaceuticals Incorporated | 1626 |
14 |
| Bristol-myers Squibb Company | 4847 |
13 |
| Bayer Pharma AG | 1055 |
13 |
| Kymera Therapeutics, Inc. | 240 |
13 |
| Arvinas Operations, Inc. | 241 |
13 |
| Merck Patent GmbH | 5777 |
11 |
| Repare Therapeutics, Inc. | 59 |
10 |
| Novartis AG | 10674 |
9 |
| Mirati Therapeutics, Inc. | 269 |
9 |
| Taisho Pharmaceutical Co., Ltd. | 860 |
9 |
| Janssen Pharmaceutica N.V. | 3352 |
8 |
| Amgen Inc. | 4147 |
8 |
| Gilead Sciences, Inc. | 2065 |
8 |
| Other owners | 729 |